Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 2, Issue , 2012, Pages 20-28

  Osei Atweneboana, Mike Y ^a,e   Boakye, Daniel A ^b   Awadzi, Kwablah ^c   Gyapong, John O ^d   Prichard, Roger K ^a  

^a MCGILL UNIVERSITY   (Canada)

^b University of Ghana   (Ghana)

^c Onchocerciasis Chemotherapy Research Center   (Ghana)

^d UNIVERSITY OF GHANA   (Ghana)

^e CSIR WATER RESEARCH INSTITUTE   (Ghana)

Author keywords

Anthelmintic resistance; Genetic changes; Ivermectin; Onchocerca volvulus

Indexed keywords

BETA TUBULIN; IVERMECTIN;

ARTICLE; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; WORM;

EID: 84861467560     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2012.01.005     Document Type: Article

References (36)

1. Abiose A. Onchocercal eye disease and the impact of Mectizan treatment. Ann. Trop. Med. Parasitol. 1998, 92:S1-S22.
2. Ali M.M.M., Mukhtar M.M., Baraka O.Z., Homeida M.M.A., Kheir M.M., Mackenzie C.D. Immunocompetence may be important in the effectiveness of Mectizan® (ivermectin) in the treatment of human onchocerciasis. Acta Trop. 2002, 84:49-53.
3. Anderson T.J.C., Blouin M.S., Beech R.N. Population biology of parasitic nematodes: application of genetic markers. Adv. Parasitol. 1998, 41:219-283.
4. Awadzi K., Dadzie K.Y., Kläger S., Gilles H.M. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis, patients in northern Ghana, a region with long lasting vector control. Trop. Med. Parasitol. 1989, 40:361-366.
5. Awadzi K., Boakye D.A., Edwards G., Opoku N.O., Attah S.K., Osei-Atweneboana M.Y., Lazdins-Helds J.K., Ardrey A.E., Addy E.T., Quartey B.T., Ahmed K., Boatin B.A., Soumbey-Alley E.W. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 2004, 98:231-249.
6. Awadzi K., Attah S.K., Addy E.T., Opoku N.O., Quartey B.T., Lazdins-Helds J.K., Ahmed K., Boatin B.A., Boakye D.A., Edwards G. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 2004, 98:359-370.
7. Basáñez M.G., Pion S.D.S., Churcher T.S., Breitling L.P., Little M.P., Boussinesq M. River blindness: a success story under threat?. PLoS Med. 2006, 3:e371.
8. Blackhall W.J., Prichard R.K., Beech R.N. Selection at a γ-aminobutyric acid receptor gene in Haemonchus contortus resistant to avermectins/milbemycins. Mol. Biochem. Parasitol. 2003, 131:137-145.
9. Bourguinat C., Pion S.D., Kamgno J., Gardon J., Duke B.O., Boussinesq M., Prichard R.K. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis. 2007, 1((1)e72):12-22.
10. Boussinesq M., Gardon J. Ivermectin-clinical trials and treatment schedules in onchocerciasis. Acta Leidesia 1999, 59:160-175.
11. Brieger W.R., Awedoba A.K., Eneanya C.I., Hagan M., Ogbuagu K.F., Okello D.O., Ososanya O.O., Ovuga E.B., Noma M., kale O.O., Burnham G.M., Remme J.H. The effect of ivermectin on Onchocerca skin disease and severe itching: results of a multicenter trial. Trop. Med. Int. Health 1998, 3:951-961.
12. Brown K.R., Neu D.C. Ivermectin-clinical trials and treatment schedules in onchocerciasis. Acta Leidensia 1990, 59:169-175.
13. Chavasse D.C., Post R.J., Lemoh P.A., Whitworth J.A. The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. Trop. Med. Parasitol. 1992, 43:256-262.
14. Churcher T.S., Pion S.D.S., Osei-Atweneboana M.Y., Prichard R.K., Awadzi K., Boussinesq M., Collins R.C., Beatriz Muñoz B., Whitworth J.A., Basáñez M.-G. Identifying sub-optimal responses to ivermectin in the treatment of river blindness. Proc. Natl. Acad. Sci. USA 2009, 106:16716-16726.
15. Duke B.O.L., Zea-Flores G., Castro J., Cupp E.W., Munoz B. Effect of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am. J. Trop. Med. Hyg. 1990, 43:657-664.
16. Eng J.K., Prichard R.K. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol. Biochem. Parasitol. 2005, 142:193-202.
17. Eng J.K., Blackhall W.J., Osei-Atweneboana M.Y., Bourguinat C., D.Beech R.N., Unnasch T.R., Awadzi K., Lubega G.W., Prichard R.K. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol. 2006, 50:229-235.
18. Fischer P., Kipp W., Kabwa P., Buttner D.W. Onchocerciasis and human immunodeficiency virus in Western Uganda: prevalences and treatment with ivermectin. Am. J. Trop. Med. Hyg. 1995, 53:171-178.
19. Freeman A., Nghiem C., Li J., Ashton F., Guerrero J., Shoop W., Schad G. Amphidial structure of ivermectin resistant and susceptible laboratory and field strains of Haemonchus contortus. Vet. Parasitol. 2003, 110:217-226.
20. Geary T.G., Nulf S.C., Alexander-Bowman S.J., Mahmoud B.M., Prichard R.K., Klein R.D. Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and Onchocerca volvulus. J. Parasitol. 1998, 84:356-360.
21. Grant W. What is the real target for ivermectin resistance in Onchocerca volvulus. Parasitol. Today 2000, 16:458-459.
22. Jackson F. Anthelmintic resistance - the state of play. Brit. Vet. J. 1993, 149:123-138.
23. Kelly J.D., Whitlock H.V., Thompson H.G., Hall C.A., Martin I.C., Le Jambre L.F. Physiological characteristics of free-living and parasitic stages of strains of Haemonchus contortus, susceptible or resistant to benzimidazole anthelmintics. Res. Vet. Sci. 1978, 25:376-385.
24. Kläger S.L., Whitworth J.A.G., Downham M.D. Viability and fertility of adult Onchocerca volvulus after 6years of treatment with ivermectin. Trop. Med. Int. Health 1996, 1:581-589.
25. Moreno Y., Nabhan J.F., Solomon J., Mackenzie C.D., Geary T.G. Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc. Natl. Acad. Sci. USA 2010, 107:20120-20125.
26. Mottier M.L., Prichard R.K. Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus. Pharmacogen. Genomics 2008, 18:129-140.
27. Njue A., Hayashi J., Kinne L., Feng X.P., Prichard R. Mutations in the extracellular domains of glutamate-gated chloride channel a3 and b subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity. J. Neurochem. 2004, 89:1137-1147.
28. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., Gyapong J.O., Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007, 369:2021-2029.
29. Osei-Atweneboana M.Y., Awadzi K., Atta S.K., Boakye D.A., Gyapong J.O., Prichard R.K. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. Plos Negl. Trop. Dis. 2011, 5(3):e998.
30. Plaisier A.P., Alley E.S., Boatin B.A., van Oortmarssen G.J., Remme H., de Vlas S.J., Bonneux L., Habbema J.D. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the onchocerciasis control program in West-Africa. J. Infect. Dis. 1995, 172:204-210.
31. Prichard R.K. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?. Vet. Parasitol. 2005, 133:243-253.
32. Prichard R.K., Hall C.A., Kelly J.D., Martin I.C., Donald A.D. The problem of anthelmintic resistance in nematodes. Aust. Vet. J. 1980, 56:239-251.
33. Remme J.H.F., Amazigo U., Engels D., Barryson A., Yameogo L. Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 2007, 370:1123-1124.
34. Schulz-Key H. The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug trials. Trop. Med. Parasitol. 1988, 39:423-440.
35. Shoop W.L. Ivermectin resistance. Parasitol. Today 1993, 9:154-159.
36. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 1998, 91:327-335.